Multi Radiance Medical Leads the Industry in Clinical Research to Provide Superior Device Innovation, Improving Patient Outcomes
SOLON, Ohio — Multi Radiance Medical (MRM), a global leader in therapeutic light devices proudly announces that two of its senior research team members, Dr. Ernesto Cesar Pinto Leal-Junior and Dr. Janis T. Eells, have been recognized on the 2025 Stanford University Top 2% Scientists List for their influential work in photobiomodulation research.
What is the Stanford List?
The list, compiled from Scopus citation data, recognizes the global top 2% of researchers. Inclusion reflects a sustained, high-impact scholarly career through citations, publications, and significant contributions to scientific understanding.
Why It Matters
This honor validates the rigorous, evidence-based science that Multi Radiance Medical pursues. It reinforces the company’s commitment to advancing photobiomodulation as a clinically proven therapeutic option, positioning Multi Radiance Medical as a leader in bridging research with patient care.
Meet the Honorees
Dr. Leal-Junior has spent more than 12 years as MRM’s Senior Researcher and Head of the Laboratory of Phototherapy and Innovative Technologies (LaPIT), authoring numerous peer-reviewed clinical studies that explore light-based therapies for pain, inflammation, and tissue repair. His work has helped shape clinical protocols and informed device development across the industry. Dr. Eells brings decades of research experience in photobiology and clinical applications, contributing seminal studies that bridge basic science and patient-centered outcomes. Both researchers have contributed to multi-center trials, systematic reviews, and educational initiatives that support safe and effective use of photobiomodulation technologies.
“Recognition on the Stanford Top 2% list is an important validation of the rigorous science our team pursues,” said Dr. Leal-Junior. “This honor reflects not only our individual efforts but the collaborative environment at Multi Radiance Medical, where research, clinical insight, and device innovation come together to improve patient care.”
About Multi Radiance Medical
Multi Radiance Medical continues to invest in independent and collaborative research to expand evidence for noninvasive light therapies. The company supports peer-reviewed clinical trials, academic partnerships, and open dissemination of results to ensure clinicians and patients have access to reliable data. The inclusion of Drs. Leal-Junior and Eells on the Stanford list reinforces MRM’s commitment to scientific excellence and positions the company to continue advancing photobiomodulation as a validated therapeutic option in clinical practice.
Multi Radiance Medical is a global leader in therapeutic light devices and clinical research for photobiomodulation. The company develops evidence-based, FDA-cleared devices aimed at improving outcomes in pain management, rehabilitation, and wound care. For over 20 years, through partnerships with academic institutions and healthcare professionals, MRM focuses on delivering clinically validated technology and education to support safe and effective patient treatment in the fields of rehabilitation, chiropractic, physiatry, sports medicine and veterinary markets.
Download the article as a PDF here